STOFF 2017 | Society for Translational Oncology

2017 STO Fellows’ Forum (STOFF)

October 12-15, 2017
Lansdowne in Leesburg, VA
2017 STOFF Agenda (PDF)

Topic: Personalized Cancer Treatment
Bruce A. Chabner, MD
Summary (PDF)

Topic: Issues in Design of Translational Research Trials
Susan Hilsenbeck, PhD
Summary (PDF)

Topics: IRB Issues and Translational Research
PI Responsibilities and Conflict of Interest
Stacey Berg, MD
Summary 1 (PDF) | Summary 2 (PDF)

Topic: CAR T Cell Therapies for Myeloma
Eric Smith, MD, PhD
Summary (PDF)

Topics: Phase 1 Clinical Trials: Hypothesis Testing
How to Write a Grant
Keith Flaherty, MD
Summary 1 (PDF) | Summary 2 (PDF)

Topic: Lessons From Translational Research in Myeloid Leukemia
Ross Levine, MD
Summary (PDF)

Topics: Cancer Drug Development: Views from Industry and Academia
Introduction to Drug Development
Bernardo Goulart, MD, MS
Summary (PDF)

Topic: The Cost and Value of Cancer Medicine
Thomas G. Roberts, Jr., MD, MSoc Sci
Summary (PDF)

Topic: The Cancer Genome Atlas (TCGA)
William Kim, MD
Summary (PDF)

Topic: Guidelines for Good Basic Research
Mark W. Duncan, PhD
Summary (PDF)

Topic: Immune Checkpoint Inhibition in Advanced Cancer
Michael Postow, MD
Summary(PDF)

Topic: Pharmacogenomics
Peter H. O’Donnell, MD
Summary (PDF)

Topic: Oncology Drug Development: A Regulatory Perspective
Tatiana Prowell, MD
Summaries (PDF)

The Society for Translational Oncology gratefully acknowledges educational grants in partial support of this activity from:

Amgen
EcoR1 Capital
Takeda Oncology
Pfizer
CHAAO